ホームページ Immunology & Inflammation -NF-κB NOD

NOD

NOD製品

  • All (4)
  • NOD阻害剤 (2)
  • NOD作動薬(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2863 Nodinitib-1 (ML130) Nodinitib-1(ML130) is a potent and selective inhibitor of NOD1 with IC50 of 0.56 μM, inhibits NF-κB activation, exhibits 36-fold selectivity over NOD2.
Cells, 2023, 12(5)696
J Neuroinflammation, 2020, 17(1):364
J Immunol, 2020, 205(3):811-821
S0004 NOD-IN-1 NOD-IN-1 (MDK19922, Compound 4) is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptor 1 (NOD1) and NOD2 with IC50 of 5.74 μM and 6.45 μM, respectively.
PLoS Pathog, 2023, 19(6):e1011455
S0349 Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b.
S0349 Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b.
S2863 Nodinitib-1 (ML130) Nodinitib-1(ML130) is a potent and selective inhibitor of NOD1 with IC50 of 0.56 μM, inhibits NF-κB activation, exhibits 36-fold selectivity over NOD2.
Cells, 2023, 12(5)696
J Neuroinflammation, 2020, 17(1):364
J Immunol, 2020, 205(3):811-821
S0004 NOD-IN-1 NOD-IN-1 (MDK19922, Compound 4) is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptor 1 (NOD1) and NOD2 with IC50 of 5.74 μM and 6.45 μM, respectively.
PLoS Pathog, 2023, 19(6):e1011455
S0349 Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b.

NOD阻害剤の選択性比較

NODシグナル伝達経路

NODシグナル伝達経路
Tags: NOD inhibitor|NOD agonist|NOD activator|NOD inducer|NOD antagonist|NOD signaling pathway|NOD assay kit